Aktiia Secures $42M in Series-B Funding, Total Funds Reach $100M
Deal News | May 28, 2025 | Legal Community Swiss
Aktiia, a company specializing in blood pressure intelligence platforms, has successfully completed a Series-B funding round, raising $42 million and bringing their total funding to date to $100 million. The funding round was co-led by Earlybird Health and Wellington Partners, with new investors including Kfund and naturalX Health Ventures joining the fray. Existing investors like Redalpine, Khosla Ventures, Molten Ventures, Translink Capital, and Verve Ventures also participated. Vischer, a legal advisory firm, played a prominent role by advising the co-leads and new investors during this transaction. The Vischer team was spearheaded by partner Matthias Staehelin and included several associates across corporate/M&A and tax expertise. This successful round underlines the growing investor interest in health technology platforms that offer innovative solutions to health monitoring.
Sectors
- Healthcare Technology
- Venture Capital
- Legal Advisory
Geography
- Switzerland – Vischer, the legal advisory firm involved, is based in Switzerland, indicating its relevance in the geographical context.
- Global – The investors involved in the funding round, such as Khosla Ventures and Translink Capital, contribute to a global investment network.
Industry
- Healthcare Technology – Aktiia operates within the healthcare technology sector, developing platforms that enable intelligent blood pressure monitoring.
- Venture Capital – The article discusses a Series-B funding round, indicating a significant presence of venture capital investments from firms like Earlybird Health and Wellington Partners.
- Legal Advisory – Vischer provided legal consulting for the funding round, showcasing their role in the legal advisory sector for corporate and M&A transactions.
Financials
- USD 42 million – The amount raised during Aktiia's Series-B funding round.
- USD 100 million – The total funding Aktiia has raised to date.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Aktiia | Target | Company | Aktiia is a health technology company focused on providing intelligent blood pressure monitoring solutions. |
| Vischer | Legal Advisor | Company | Vischer is a law firm that advised on the Series-B funding round for Aktiia. |
| Earlybird Health | Co-lead Investor | Company | A venture capital firm that co-led the Series-B funding round for Aktiia. |
| Wellington Partners | Co-lead Investor | Company | A venture capital firm that co-led the Series-B funding round for Aktiia. |
| Kfund | New Investor | Company | A new investor participating in Aktiia's Series-B funding round. |
| naturalX Health Ventures | New Investor | Company | A new investor participating in Aktiia's Series-B funding round. |
| Redalpine | Existing Investor | Company | An existing investor participating in Aktiia's Series-B funding round. |
| Khosla Ventures | Existing Investor | Company | An existing investor participating in Aktiia's Series-B funding round. |
| Molten Ventures | Existing Investor | Company | An existing investor participating in Aktiia's Series-B funding round. |
| Translink Capital | Existing Investor | Company | An existing investor participating in Aktiia's Series-B funding round. |
| Verve Ventures | Existing Investor | Company | An existing investor participating in Aktiia's Series-B funding round. |
| Vischer Team Members | Advisory Team | People | Members included partner Matthias Staehelin, managing associate Vincent S. Reardon, and others specializing in corporate/M&A and tax. |